This product is protected by Hilma Biocare™ Verification

Download Letrozole Product Test

Want to be Hilma Biocare
products Reseller?

Become a Partner

Specifications Letrozole:

Company: Hilma Biocare
Active Half-life (Days):  2-3 days
Group: Aromatase inhibitor
Subgroup: Oral/tablets
Dosage: 2.5 mg/tab
Application (Men): 0.5 to 1 mg throughout 1 to 3 days
Product pack: 30 tab.
Content (active): Letrozole
Retains water: No
Aromatization: No

Product Description

Letrozole is an antitumor agent, a non-steroidal selective inhibitor of the aromatase enzyme. Widely used in medicine as a part of post-menopausal therapy in women and breast cancer treatment. Among athletes gained recognition for strong anti-estrogenic properties and raised muscle definition. Like Anastroloze(Arimidex), its effect is up to 5 times stronger, eliminating adverse reactions from anabolic steroid use. Letrozole can suppress estrogen levels in the body, almost wholly shielding from raised estradiol levels.


By using Letrozole athletes can almost wholly suppress estrogen level in the body and protects themselves against aromatization.


The most common side effects attributed to Letrozole are skin rash, nausea, abdominal pain, fatigue, dizziness, headache, raised Low-density cholesterol levels and liver enzymes.


Preliminary blood test should be conducted before using Letrozole. Results in colossal estradiol reduction and increasing the effectiveness of your cycle. Letrozole served as an anti-estrogenic drug and was used as a part of PCT.


Letrozole is most effective during PCT but can be stacked with clomiphene or other steroids as a part of the cycle.


Protection code:
How it works:

Hilma Biocare™ takes care of consumers and regularly develops various means of protecting its products, which ensures patient safety and trust to verify our products

Package sizes:

Want to be Hilma Biocare products Reseller?

Please contact our manager to discuss collaboration details directly via Message form.

Become a Partner